Skip to main content
. 2016 Nov 8;17(2):97–107. doi: 10.1007/s40256-016-0200-5

Fig. 3.

Fig. 3

Annual absolute effects per 1000 of cyclooxygenase-2-selective non-steroidal anti-inflammatory drugs (NSAIDs) and traditional tNSAIDs at different baseline risks of major vascular events. For each drug category, the predicted annual absolute risks of major vascular events (±1 standard error) are shown for patients with predicted risk of 2.0 % (high risk) or 0.5 % (low risk) per annum of a major vascular event. Data from the CNT meta-analysis [68]. SE standard error